Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to test the efficacy of an educational therapeutic intervention in treating obesity in a pediatric population.
It aims to verify the differences between the experimental group (group-based program) and the control group (individual program) in respect to the BMI z-score values between baseline measurement (beginning of treatment), final measurement (end of treatment) and 18 months follow-up.
One of the aim of this clinical trial is to verify that the direct management of the emotional and relational aspects of patients and family plays an important role in maintaining the weight changes achieved in the long term.
The potential added value of the present study concerns the better understanding of the role of psychological and emotional aspects in the treatment of childhood obesity and in maintaining results in the long term.
The clinical trial aims to recruit 300 obese children randomized in two groups: experimental group and control group.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Therapeutic group intervention | Experimental | Patients will be called in groups every 3 months for a total of 10 meetings. At each meeting they will be weighed and measured. Each meeting will focus on a topic of nutritional/lifestyle interest and will see the co-presence of the figures of the dietician and the psychologist, in order to allow an emotional declination for all the participants. |
|
| Usual care | Active Comparator | Patients will be called individually every 3 months for a total of 10 meetings. At each meeting they will be weighed and measured. Each meeting will focus on a topic of nutritional/lifestyle interest. The meetings will be conducted by a dietician. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Therapeutic Group | Behavioral | The first part of each meeting, lasting 45 minutes, will be held only with children and young people, while parents will wait in the waiting room. At the end of the first part, for each meeting, the children will be asked to make a commitment relating to the topics covered, which will be verified in the following meeting. Once the part with the patients has concluded, they will be accompanied to an adjacent environment where a pediatrician volunteer will be waiting for them and will offer fun and socialization activities. In the meantime, the parents will be seated and will address, together with the team staff, the same issues discussed with their children, again for a duration of approximately 45 minutes. Parents will also be invited to make a commitment similar to that required of children. |
| Measure | Description | Time Frame |
|---|---|---|
| BMI z-score | BMI z-score variation from baseline to end of treatment | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| BMI z-score | BMI z-score variation from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Measure | Description | Time Frame |
|---|---|---|
| healthy dietary habits | variation in the daily consumption (in frequency) of fruits and vegetables measurement at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| healthy dietary habits |
Not provided
Inclusion Criteria:
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marta Fontana, Psycologist | Azienda USL - IRCCS di Reggio Emilia | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26520237 | Background | Panebianco D, Gallupe O, Carrington PJ, Colozzi I. Personal support networks, social capital, and risk of relapse among individuals treated for substance use issues. Int J Drug Policy. 2016 Jan;27:146-53. doi: 10.1016/j.drugpo.2015.09.009. Epub 2015 Sep 28. | |
| 17438555 | Background | Kalavainen MP, Korppi MO, Nuutinen OM. Clinical efficacy of group-based treatment for childhood obesity compared with routinely given individual counseling. Int J Obes (Lond). 2007 Oct;31(10):1500-8. doi: 10.1038/sj.ijo.0803628. Epub 2007 Apr 17. |
| Label | URL |
|---|---|
| BMI definition | View source |
Not provided
We do not have the authorization to share IPD. We are in the process to agree with the Ethic Committee how the share data.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D063766 | Pediatric Obesity |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D012657 | Self-Help Groups |
| ID | Term |
|---|---|
| D009938 | Organizations |
| D004472 | Health Care Economics and Organizations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Usual care | Behavioral | The dietician will meet individually each child together with parents. Dietician will provide nutritional advices. |
|
variation in the daily consumption (in frequency) of fruits and vegetables measurement from baseline to 18 months after the and of treatment |
| measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| unhealthy dietary habits | variation in the weekly consumption (in frequency) of packed and high-calorie food measurment at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| unhealthy dietary habits | variation in the weekly consumption (in frequency) of packed and high-calorie food measurment from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Uric acid | variation in the value measurements (differences expressed in mg/dL) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Transaminases | variation in the value measurements (differences expressed in U/l) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Glycemia | variation in the value measurements (differences expressed in mg/dL) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Insulin | variation in the value measurements (differences expressed in µU/mL) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Glycated hemoglobin | variation in the value measurements (differences expressed mmol/moli) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Cholesterol | variation in the value measurements (differences expressed mg/dL) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Triglycerides | variation in the value measurements (differences expressed mg/dL) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Thyroid-stimulating hormone | variation in the value measurements (differences expressed μIU/ml) at end of treatment i.e approximately 24 months after baseline measurements | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Biohumoral exams from blood sample: Uric acid | variation in the value measurements (differences expressed in mg/dL) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Transaminases | variation in the value measurements (differences expressed in U/l) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Glycemia | variation in the value measurements (differences expressed in mg/dL) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Insulin | variation in the value measurements (differences expressed in µU/mL) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Glycated hemoglobin | variation in the value measurements (differences expressed in mmol/moli) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Cholesterol | variation in the value measurements (differences expressed in mg/dL) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Triglycerides | variation in the value measurements (differences expressed in mg/dL) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Biohumoral exams from blood sample: Thyroid-stimulating hormone | variation in the value measurements (differences expressed in μIU/ml) from baseline to 18 months after the and of treatment | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Psychological questionnaire TAS-20 (Toronto Alexithymia Scale) | variation in TAS-20 overall and sub-scale scores (differences) from baseline to the end of treatment i.e approximately 24 months after baseline measurements.Scoring range: 20-100; cutoff 60 (higher scores indicate greater impairment/challenges). | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Psychological questionnaire TAS-20 (Toronto Alexithymia Scale) | variation in TAS-20 overall and sub-scale scores (differences) from baseline to approximately 18 months after the end of treatment. Scoring range: 20-100; cutoff 60 (higher scores indicate greater impairment/challenges). | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Psychological questionnaire PEDSQL (Pediatric Quality of life) | variation in PEDSQL overall and sub-scale scores (differences) from baseline to the end of treatment i.e approximately 24 months after baseline measurements. Scores are linearly transformed to a 0-100 scale in which high score means better condition. | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Psychological questionnaire PEDSQL (Pediatric Quality of life) | variation in PEDSQL overall and sub-scale scores (differences) from baseline to approximately 18 months after the end of treatment. Scores are linearly transformed to a 0-100 scale in which high score means better condition. | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Psychological questionnaire CBCL (Child Behaviour Checklist) | variation in CBCL overall and sub-scale scores (differences) from baseline to the end of treatment i.e approximately 24 months after baseline measurements. Scores below the 93rd percentile is considered normal, scores between the 93-97th percentile are borderline clinical, and scores above the 97th percentile are in the clinical range. | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| Psychological questionnaire CBCL (Child Behaviour Checklist) | variation in CBCL overall and sub-scale scores (differences) from baseline to approximately 18 months after the end of treatment. Scores below the 93rd percentile is considered normal, scores between the 93-97th percentile are borderline clinical, and scores above the 97th percentile are in the clinical range | measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements |
| Drop-out | qualitative differences between experimental and control group in drop-out per cent | measurement at end of treatment i.e approximately 24 months after baseline measurements |
| 15238894 | Background | Zeller M, Daniels S. The obesity epidemic: family matters. J Pediatr. 2004 Jul;145(1):3-4. doi: 10.1016/j.jpeds.2004.04.038. No abstract available. |
| 9019048 | Background | Braet C, Mervielde I, Vandereycken W. Psychological aspects of childhood obesity: a controlled study in a clinical and nonclinical sample. J Pediatr Psychol. 1997 Feb;22(1):59-71. doi: 10.1093/jpepsy/22.1.59. |
| 11274524 | Background | French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Annu Rev Public Health. 2001;22:309-35. doi: 10.1146/annurev.publhealth.22.1.309. |
| 14620250 | Background | Trombini E, Baldaro B, Bertaccini R, Mattei C, Montebarocci O, Rossi N. Maternal attitudes and attachment styles in mothers of obese children. Percept Mot Skills. 2003 Oct;97(2):613-20. doi: 10.2466/pms.2003.97.2.613. |
| 17449466 | Background | Goldfield GS, Mallory R, Parker T, Cunningham T, Legg C, Lumb A, Parker K, Prud'homme D, Adamo KB. Effects of modifying physical activity and sedentary behavior on psychosocial adjustment in overweight/obese children. J Pediatr Psychol. 2007 Aug;32(7):783-93. doi: 10.1093/jpepsy/jsm017. Epub 2007 Apr 19. |
| 15347700 | Background | Braet C, Tanghe A, Decaluwe V, Moens E, Rosseel Y. Inpatient treatment for children with obesity: weight loss, psychological well-being, and eating behavior. J Pediatr Psychol. 2004 Oct;29(7):519-29. doi: 10.1093/jpepsy/jsh054. |
| 20462509 | Background | Hingle MD, O'Connor TM, Dave JM, Baranowski T. Parental involvement in interventions to improve child dietary intake: a systematic review. Prev Med. 2010 Aug;51(2):103-11. doi: 10.1016/j.ypmed.2010.04.014. Epub 2010 May 10. |
| 24693926 | Background | Fonseca H, Palmeira AL, Martins SC, Falcato L, Quaresma A. Managing paediatric obesity: a multidisciplinary intervention including peers in the therapeutic process. BMC Pediatr. 2014 Apr 3;14:89. doi: 10.1186/1471-2431-14-89. |
| 25981555 | Background | Kader M, Sundblom E, Elinder LS. Effectiveness of universal parental support interventions addressing children's dietary habits, physical activity and bodyweight: A systematic review. Prev Med. 2015 Aug;77:52-67. doi: 10.1016/j.ypmed.2015.05.005. Epub 2015 May 14. |
| 17845100 | Background | Wilfley DE, Tibbs TL, Van Buren DJ, Reach KP, Walker MS, Epstein LH. Lifestyle interventions in the treatment of childhood overweight: a meta-analytic review of randomized controlled trials. Health Psychol. 2007 Sep;26(5):521-32. doi: 10.1037/0278-6133.26.5.521. |
| 17723034 | Background | Epstein LH, Leddy JJ, Temple JL, Faith MS. Food reinforcement and eating: a multilevel analysis. Psychol Bull. 2007 Sep;133(5):884-906. doi: 10.1037/0033-2909.133.5.884. |
| 24144717 | Background | Davoli AM, Broccoli S, Bonvicini L, Fabbri A, Ferrari E, D'Angelo S, Di Buono A, Montagna G, Panza C, Pinotti M, Romani G, Storani S, Tamelli M, Candela S, Giorgi Rossi P. Pediatrician-led motivational interviewing to treat overweight children: an RCT. Pediatrics. 2013 Nov;132(5):e1236-46. doi: 10.1542/peds.2013-1738. Epub 2013 Oct 21. |
| national surveillance system Okkio alla SALUTE | View source |
| D009750 |
| Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |